Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of SANGUINATE for the Treatment of Vaso-occlusive Crisis (VOC) in Adult Sickle Cell Disease Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02672540
Recruitment Status : Completed
First Posted : February 3, 2016
Last Update Posted : May 23, 2018
Sponsor:
Information provided by (Responsible Party):
Prolong Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 31, 2017
Actual Study Completion Date : May 31, 2017